Internet-based Self-help for Negative Life Events (ZIEL)

October 10, 2019 updated by: University of Bern

ZIEL - Zurück Ins Eigene Leben - Internet-based Self-help for Negative Life Events

The purpose of the study is to investigate the efficacy of an internet-based self-help intervention for dealing with stressful life events.

Study Overview

Status

Completed

Detailed Description

The purpose of the study is to investigate the efficacy of an internet-based self-help intervention for dealing with stressful life events compared to a waiting list, in a randomized controlled trial design. Assessments are at baseline, 4-week and 3 months post-randomization. After 4 weeks, participants in the waiting control group get also access to the intervention.

Study Type

Interventional

Enrollment (Actual)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3012
        • University of Bern
      • Zürich, Switzerland, 8050
        • Universität Zürich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Negative life event in a period between two weeks and two years before the study
  • Internet account
  • Sufficient German language skills
  • Informed consent

Exclusion Criteria:

  • Persons with moderate or severe depressive symptoms
  • Acute suicidality
  • Psychotic disorder, bipolar disorder
  • Severe, acute mental or physical disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active Group
Internet-based self-help
The intervention provided is based on the principles of cognitive behavioral therapy (CBT) (Bachem & Maercker, 2013). The manual integrates a variety of approaches validated as treatments for PTSD, anxiety disorders, or depression; the selection focuses on exercises which are intended to target the main symptoms of AjD, namely preoccupations (e.g. constant rumination, excessive worry about the stressor) and failure to adapt (e.g. sleep disturbance, difficulties concentrating, loss of interest in previously enjoyable activities).
No Intervention: Waiting List Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adjustment Disorder - New Module 20 (ADNM-20)
Time Frame: 4-week

The ADNM-20 is a self-report assessment for adjustment disorder. It is aimed at adults who feel burdened by a critical life event.

The ADNM-20 consists of two parts: an event list for recording stress and an item list for recording the resulting symptoms. In the event list, all burdens during the last two years are recorded and the subjectively highest burdens are named. On the basis of the item list, preoccupations and mismatch, the main symptom groups of the adaptation disorder according to ICD-11, as well as the concomitant symptoms of avoidance, depressiveness, anxiety, impulse control problems and functional impairment are recorded.

The scale ranges from 0 (no stress) to 80 (high exposure).

4-week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Symptom Inventory - Short Version (BSI-18)
Time Frame: 4-week

The short version of the Brief Symptom Inventory (BSI-18) is an easily applicable, reliable and valid self-report measure in wide international use. It assesses the syndromes of somatisation, depression and anxiety by means of 6 items each.

The global factor ranges from 0 (no symptoms) to 72 (high symptomatic burden).

4-week
Beck Depression Inventory (BDI)
Time Frame: 4-week

The BDI is a 21-question multiple-choice self-report inventory, one of the most widely used psychometric tests for measuring the severity of depression.

The score ranges from 0 (no symptoms) to 63 (severe depression).

4-week
Short Form 12-Item Survey (SF-12)
Time Frame: 4-week

The SF-12 consists of 12 questions and is a general health questionnaire that provides information on the patient's state of health in more than 8 different dimensions.

Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

4-week
Sense of Coherence Questionaire Revised (SOC-R)
Time Frame: 4-week

The SOC-R is a new conceptualization and operationalization of the resilience indicator SOC.

The total score ranges from 13 (low) to 65 (high SOC).

4-week
Questionnaire for measuring patient satisfaction (ZUF-8)
Time Frame: 4-week

The ZUF-8 is a self-assessment tool to assess the patient's satisfaction with regard to aspects of the clinic and treatment.

The scale ranges from 8 (bad) to 32 (good satisfaction).

4-week
Credibility/Expectancy Questionaire (CEQ)
Time Frame: 4-week

The CEQ is a scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies.

The CEQ utilizes two scales during the administration (1-9, and 0-100%).

4-week
System Usability Scale (SUS)
Time Frame: 4-week

The System Usability Scale (SUS) is a simple and technology-independent questionnaire to evaluate the usability of a system.

The score ranges from 0 (worst) to 100 (best).

4-week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Andreas Maercker, Prof., Universität Zürich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

February 1, 2019

Study Completion (Actual)

March 1, 2019

Study Registration Dates

First Submitted

December 14, 2017

First Submitted That Met QC Criteria

December 14, 2017

First Posted (Actual)

December 20, 2017

Study Record Updates

Last Update Posted (Actual)

October 14, 2019

Last Update Submitted That Met QC Criteria

October 10, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • ZIEL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adjustment Disorders

Clinical Trials on Internet-based self-help program

3
Subscribe